I don't think that onesurfed is "seeking out broker reports"....

First 9 Last

Share
Profile

Follow
Gofish1

909 Posts.

101

26/11/20

12:08

Post #: 49161782
Share

Originally posted by needle: ↑

To suggest yesterday by a broker, I can't come to name......that Paxalisib has a 35% chance of success, is a insult to the intelligence of investors in this company. Indeed the Chairman himself has purchased nearly 1 million dollars worth of shares in the company....most of it in recent times - now we hear from the broker yesterday, its got a 35% chance.

The 35% alone is less than the arithmetic mean, for all drug trials going from 2 to Phase 3.

It is a slap in the face of people who have donated millions of dollars into GBM research.....some of these funds are going into research into the KZA drug in the GBM AGILE Trial.

These top people in the world - have selected Paxalisib above dozens of other drug - but oh no, a 35% chance. And that is for GBM - maybe something should tell Priscilla Brastanious, you are about 10/1 in brain mets.

Why would the company publish this rubbish ?....I have come to know them. They have an existing contract with that unnamed broker. To the very much credit of the company - they are scrupulously honest in doing the right thing - and regardless of what the broker comes up with - it gets published. Of course honest and integrity is a good thing - How many other small cap companies in Aust would actually publish this, I have a view on, but won't say.

So point is onesurfed - why are you seeking out broker reports when you have all this research coming through. If indeed you accept broker advice - surely you will be selling on what we had yesterday. (But hopefully you will regard something I have said here)

Expand

I don't think that onesurfed is "seeking out broker reports". More stirring them up to revise their inadequate valuation.

His other posts speak for themselves.

KZA Price at posting: $1.34 Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 19 more messages in this thread...

First 9 Last

Add KZA (ASX) to my watchlist

I don't think that onesurfed is "seeking out broker reports"....

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News